They mainly observed a two-fold increase in tryptophan concentration in the serum and CSF of ALS patients, and two- and ten-fold increases in kynurenine in serum and CSF, respectively, along with a four-fold increase in IDO-1 activity in CSF. This evidence concerns the gene IDO1 and amyotrophic lateral sclerosis.